Denali Advisors LLC Has $3.53 Million Stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Denali Advisors LLC grew its position in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 0.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 183,783 shares of the company’s stock after purchasing an additional 855 shares during the quarter. Denali Advisors LLC owned about 0.50% of Crescent Capital BDC worth $3,532,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CCAP. Janney Montgomery Scott LLC grew its position in Crescent Capital BDC by 174.1% during the third quarter. Janney Montgomery Scott LLC now owns 47,264 shares of the company’s stock worth $874,000 after buying an additional 30,018 shares in the last quarter. Franklin Resources Inc. grew its position in Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after buying an additional 66,713 shares in the last quarter. Stifel Financial Corp grew its position in Crescent Capital BDC by 53.1% during the third quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after buying an additional 23,055 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in Crescent Capital BDC during the third quarter worth approximately $1,899,000. Finally, Redhawk Wealth Advisors Inc. acquired a new stake in Crescent Capital BDC during the fourth quarter worth approximately $659,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on CCAP. Keefe, Bruyette & Woods increased their price target on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. Wells Fargo & Company cut their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.20.

Crescent Capital BDC Stock Up 0.2 %

NASDAQ CCAP opened at $18.27 on Wednesday. The business has a fifty day moving average price of $19.37 and a two-hundred day moving average price of $18.89. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. Crescent Capital BDC, Inc. has a fifty-two week low of $16.58 and a fifty-two week high of $20.19. The stock has a market capitalization of $677.12 million, a PE ratio of 9.18 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Equities analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The company also recently declared a dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.05 dividend. The ex-dividend date is Friday, February 28th. Crescent Capital BDC’s payout ratio is 84.42%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.